KANKI Yasuharu

Research field (1)： Molecular biology

Research theme for competitive and other funds (14)：

2020 - 2024 早期誘導遺伝子の継時的なヒストンコード変化を可能にする因子の探索及びその機能解析
2017 - 2020 Functional Analyses of epigenetic molecules associated with early induced transcription factors in angiogenesis
2016 - 2019 The Analysis of miRNA-mRNA network related to atherosclerosis.
2016 - 2018 Understanding mechanism of acidic pH induced tumor progression
2015 - 2018 Study of long noncoding RNAs in immune response

Show all

Papers (36)：

Yuji Sasaki, Yoshiki Higashijima, Jun-Ichi Suehiro, Takehito Sugasawa, Eri Oguri-Nakamura, Shigetomo Fukuhara, Nao Nagai, Yosuke Hirakawa, Youichiro Wada, Masaomi Nangaku, et al. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors. Biochemical and Biophysical Research Communications. 2022. 605. 16-23
Yasuharu Kanki, Masashi Muramatsu, Yuri Miyamura, Kenta Kikuchi, Yoshiki Higashijima, Ryo Nakaki, Jun-Ichi Suehiro, Yuji Sasaki, Yoshiaki Kubota, Haruhiko Koseki, et al. Bivalent-histone-marked immediate-early gene regulation is vital for VEGF-responsive angiogenesis. Cell reports. 2022. 38. 6. 110332-110332
Takashi Shimizu, Akashi Taguchi, Yoshiki Higashijima, Yasuharu Kanki, Ryo Nakaki, Yoshihiro Urade, Youichiro Wada. Inhibition of cardiac PERK signaling promotes peripartum cardiac dysfunction. Scientific reports. 2021. 11. 1. 18687-18687
Kiyokazu Shirai, Genta Nagae, Motoaki Seki, Yotaro Kudo, Asuka Kamio, Akimasa Hayashi, Atsushi Okabe, Satoshi Ota, Shuichi Tsutsumi, Takanori Fujita, et al. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma. Cancer science. 2021. 112. 7. 2855-2869
Yoshiki Higashijima, Yasuharu Kanki. Potential roles of super enhancers in inflammatory gene transcription. The FEBS journal. 2021

ｍore...

MISC (14)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page